Clinical Trials

Life Science Podcast

FDA Approves First Drug to Delay T1D + Positive Data for Pfizer’s Maternal RSV Vaccine – Xtalks Life Science Podcast Ep. 87
News

Pfizer Shares Positive Phase III Data for Maternal RSV Vaccine Candidate
Blogs

Interview with Cystic Fibrosis and Rare Disease Patient Leader Gunnar Esiason – Xtalks Life Science Podcast Ep. 83

Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease

December 15, 2022
Blogs

Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81
Blogs

FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder – Xtalks Life Science Podcast Ep. 75
COVID-19 Coverage

New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer – Xtalks Life Science Podcast Ep. 72
Life Science Podcast

Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization – Xtalks Life Science Podcast Ep. 69

Cultural-Linguistic Considerations for Successful Cognitive Endpoint Assessment in International CNS Clinical Trials

June 16, 2022

Maximize Value with 2-Way Integrations in Clinical Trial Management

May 12, 2022

Advancing Data Management and Monitoring – Change the Game With Integrated eSource/EMR/EDC

May 18, 2022

How to Avoid Significant Delays in Multi-country Studies Due to EU 536/2014 Clinical Trial Regulation

January 27, 2022

NASH Populations with Cirrhosis: Drug Development Challenges and Solutions

February 16, 2022

Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program

November 05, 2021
Blogs

How the Approval of Aducanumab Will Change Alzheimer’s Trials — Xtalks Life Science Podcast Ep. 25
Blogs

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials